» Articles » PMID: 24564868

A Review of Research on Salivary Biomarkers for Oral Cancer Detection

Overview
Journal Clin Transl Med
Publisher Wiley
Specialty General Medicine
Date 2014 Feb 26
PMID 24564868
Citations 70
Authors
Affiliations
Soon will be listed here.
Abstract

Using saliva for disease diagnostics and health surveillance is a promising approach as collecting saliva is relatively easy and non-invasive. Over the past two decades, using salivary biomarkers specifically for early cancer detection has attracted much research interest, especially for cancers occurring in the oral cavity and oropharynx, for which the five-year survival rate (62%) is still one of the lowest among all major human cancers. More than 90% of oral cancers are oral squamous cell carcinoma (OSCC) and the standard method for detection is through a comprehensive clinical examination by oral healthcare professionals. Despite the fact that the oral cavity is easily accessible, most OSCCs are not diagnosed until an advanced stage, which is believed to be the major reason for the low survival rate, and points to the urgent need for clinical diagnostic aids for early detection of OSCC. Thus, much research effort has been dedicated to investigating potential salivary biomarkers for OSCC, and more than 100 such biomarkers have been reported in the literature. However, some important issues and challenges have emerged that require solutions and further research in order to find reliable OSCC salivary biomarkers for clinical use. This review article provides an up-to-date list of potential OSCC salivary biomarkers reported as of the fall of 2013, and discusses those emerging issues. By raising the awareness of these issues on the part of both researchers and clinicians, it is hoped that reliable, specific and sensitive salivary biomarkers may be found soon-and not only biomarkers for early OSCC detection but also for detecting other types of cancers or even for monitoring non-cancerous disease activity.

Citing Articles

Epidemiology, Diagnostics, and Therapy of Oral Cancer-Update Review.

Kijowska J, Grzegorczyk J, Gliwa K, Jedras A, Sitarz M Cancers (Basel). 2024; 16(18).

PMID: 39335128 PMC: 11430737. DOI: 10.3390/cancers16183156.


Salivary biomarkers in non-invasive oral cancer diagnostics: a comprehensive review.

Vats R, Yadav P, Bano A, Wadhwa S, Bhardwaj R J Appl Oral Sci. 2024; 32:e20240151.

PMID: 39258715 PMC: 11464085. DOI: 10.1590/1678-7757-2024-0151.


Expression Profiling of EMT Transcriptional Regulators ZEB1 and ZEB2 in Different Histopathological Grades of Oral Squamous Cell Carcinoma Patients.

Baqai N, Amin R, Fatima T, Ahmed Z, Faiz N Curr Genomics. 2024; 25(2):140-151.

PMID: 38751602 PMC: 11092914. DOI: 10.2174/0113892029284920240212091903.


High prevalence of CD44 and its ligand low molecular weight hyaluronan in plasma of HNSCC patients: clinical significance.

Roy R, Chatterjee N, Khan M, Sultana F, Roy A, Naskar S Mol Biol Rep. 2024; 51(1):157.

PMID: 38252332 DOI: 10.1007/s11033-023-08950-z.


Comprehensive Assessment of Albumin and Uric Acid Levels in Oral Submucous Fibrosis: A Comparative Case-Control Study Involving Different Risk Groups.

Shetty A, Gupta N, Saigal S, Bhargava A, Giri D, Mondal A Cureus. 2024; 15(12):e49811.

PMID: 38169924 PMC: 10758585. DOI: 10.7759/cureus.49811.


References
1.
Sahebjamee M, Eslami M, AtarbashiMoghadam F, Sarafnejad A . Salivary concentration of TNFalpha, IL1 alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal. 2008; 13(5):E292-5. View

2.
Cheng Y, Rees T, Jordan L, Oxford L, OBrien J, Chen H . Salivary endothelin-1 potential for detecting oral cancer in patients with oral lichen planus or oral cancer in remission. Oral Oncol. 2011; 47(12):1122-6. PMC: 3225505. DOI: 10.1016/j.oraloncology.2011.07.032. View

3.
Pickering V, Jordan R, Schmidt B . Elevated salivary endothelin levels in oral cancer patients--a pilot study. Oral Oncol. 2006; 43(1):37-41. DOI: 10.1016/j.oraloncology.2005.12.027. View

4.
Streckfus C, Bigler L, Tucci M, Thigpen J . A preliminary study of CA15-3, c-erbB-2, epidermal growth factor receptor, cathepsin-D, and p53 in saliva among women with breast carcinoma. Cancer Invest. 2000; 18(2):101-9. DOI: 10.3109/07357900009038240. View

5.
Jehmlich N, Dinh K, Gesell-Salazar M, Hammer E, Steil L, Dhople V . Quantitative analysis of the intra- and inter-subject variability of the whole salivary proteome. J Periodontal Res. 2012; 48(3):392-403. DOI: 10.1111/jre.12025. View